Enterobacter high in stool: interpreting the finding

Published October 7, 2026 · 2 min read

Enterobacter is a genus of bacteria that can be found in the intestinal community. Some Enterobacter organisms can also cause opportunistic infections. The key distinction is between a stool finding and evidence that a particular organism is causing disease at a particular site.

On this page

Why species and setting matter

Research has recovered Enterobacter and related bacteria from the stools of people without active infection. Studies of hospital infections, by contrast, often concern selected strains and resistance patterns. Neither setting can be inferred solely from a genus-level stool number. [1]

What the GI-MAP line covers

GI-MAP reports Enterobacter as a targeted bacterial-group measurement. It does not necessarily identify a particular member of the Enterobacter cloacae complex or provide a complete resistance profile. Check the report’s method and target description before interpreting a species name found in an internet search. [2]

What a high or low value cannot diagnose

An elevated count does not establish bacteremia, a urinary infection, small intestinal bacterial overgrowth or a histamine disorder. The sample is stool; it cannot show where else bacteria are present or measure histamine production. A low count does not create a requirement to “replace” the genus.

If digestive symptoms persist, discuss their pattern and duration rather than assuming the flagged count is the cause. Evidence for assigning personalized treatment from isolated microbiome-composition findings remains limited. [3]

Common questions

Is Enterobacter the same as Enterococcus?

No. Enterococcus is a different genus. Similar names do not indicate the same bacteria or clinical significance.

Does the result show antibiotic resistance?

Not from the genus name or quantity alone. Susceptibility requires relevant additional laboratory evidence when a true infection is being investigated.

Sources and review

Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.

  1. Enterobacterales isolated from healthy subjects: primary study, 2020
  2. Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
  3. International consensus statement on microbiome testing in clinical practice (2025)

Medical review of this article is pending. For a correction or source question, contact GI MAP Test.